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Oncocytoma is a neoplasm consisting of oncocytes that is found in the salivary gland, 
kidney, and thyroid. Adrenocortical oncocytoma is particularly uncommon, and most 
cases reported are benign and nonfunctioning. Here, we report a 20 cm adrenal mass 
associated with necrosis that was identified as an oncocytic adrenocortical tumor with 
uncertain malignant potential through histopathological evaluation after its resection. 
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Oncocytoma consists of oncocytes, which are acidophilic 
epithelial cells with mitochondria accumulated in the cyto-
plasm on electron microscopy [1]. Oncocytoma has been ob-
served in the salivary glands, kidney, and thyroid. 
Adrenocortical oncocytoma is particularly rare, and the re-
ported cases are usually benign and nonfunctioning. 
However, there is no single, accurate parameter by which 
to discriminate between benign and malignant adreno-
cortical neoplasms. Benign and malignant tumors are clas-
sified mainly on the basis of a combination of clinical, bio-
chemical, and histological features [2]. Here we report a 
case of an oncocytic adrenocortical tumor. Preoperative 
imaging studies revealed an approximately 20 cm mass as-
sociated with necrosis that was considered likely to be ma-
lignant cancer. After surgical resection, it was determined 
to be of uncertain malignant potential.
CASE REPORT
A 69-year-old male with no significant medical history pre-
sented to the hospital with abdominal discomfort that had 
lasted for about 1 month. There were no specific findings 
on the physical examination except for palpation of the ab-
dominal mass. An 18.2x12.3x16.9 cm mixed solid and cystic 
mass lesion was observed in the retroperitoneal space on 
a computed tomography (CT) image of the abdomen and 
pelvis (Fig. 1A). Open abdominal biopsy of the mass was 
conducted in the hospital in October 2010 and the mass was 
identified as an adrenocortical neoplasm, but the adrenal 
mass could not be differentiated from carcinoma or adeno-
ma. The patient was then referred to our hospital for treat-
ment. Preoperative positron emission tomography-CT 
(PET-CT) showed a huge, necrotic, suprarenal mass with 
fludeoxyglucose uptake. No sites of suspected distant 
metastasis were seen. The patient underwent a left radical 
adrenalectomy, and the mass showed hypervascularity 
and severe adhesion to the surrounding tissues. The surgi-
cal specimen was 20x18.5x9 cm in size and weighed 1,700 
g (Fig. 1B).
Postoperative pathological examination showed ne-
crosis and that less than 25% of the tumor cells were clear 
cells (Fig. 2A). Immunohistochemical examination showed 
histone H3 phosphorylation and vimentin positivity (Fig. 
2B, C). This case was thus diagnosed as an oncocytic adre-
nocortical tumor with uncertain malignant potential ac-
cording to the Weiss system.
The postoperative course showed no specific findings, 
and the patient was discharged on the 9th day after the 
operation. A follow-up PET-CT around 3 months after sur-
gery showed no recurrence of the tumor (Fig. 3).Korean J Urol 2011;52:650-652
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FIG. 1. (A) Preoperative computed tomography (CT) findings. The CT image shows a huge, mixed solid and cystic mass lesion in the
retroperitoneal space (axial view A-1, coronal view A-2). (B) Gross pathology image of the tumor showing a large, multilobulated, 
mass-like lesion measuring about 20x18.5x9 cm and weighing 1,700 g.
DISCUSSION
An adrenocortical neoplasm is a common abnormality ob-
served within the adrenal cortex. Most lesions are asymp-
tomatic and are detected incidentally on evaluation for ab-
dominal pain or hypertension [3,4].
Oncocytoma consists of oncocytes, which are acidophilic 
epithelial cells that show accumulation of mitochondria in 
the cytoplasm on electron microscopy. Oncocytoma is 
found mainly in the salivary gland, kidney, and thyroid. 
Adrenocortical oncocytoma is very uncommon [5]. Peppa 
et al reported 53 cases of adrenocortical oncocytoma; in that 
series, the age at diagnosis of adrenocortical oncocytoma 
ranged from 15 to 77 years and the ratios of males to females 
and of left to right were 1:2.5 and 3.5:1, respectively [3]. The 
size and weight of the tumors were 3 to 17 cm and 30 to 1,800 
g, respectively. The distribution of benign, borderline, and 
malignant cases were 28, 14, and 11, respectively. Most 
adrenocortical oncocytomas observed are benign and non-
functioning [3,6].
FIG. 2. (A) Typical structure of an oncocytoma with abundant eosinophilic and 
granular cytoplasm (H&E, x100). (B, C) Immunohistochemically, the neoplastic cells 
were positive for histone H3 phosphorylation and vimentin, respectively.Korean J Urol 2011;52:650-652
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FIG. 3. Postoperative whole-body positron emission tomography/
computed tomography (PET/CT) scan showing no tumor 
recurrence (3 months after the operation).
To discriminate between benign and malignant tumors, 
size and weight have been emphasized as predictors of bio-
logical behavior. These are not accurate parameters, how-
ever; accordingly, other systems such as the combination 
of clinical, biochemical, and histological features have been 
used to distinguish between benign and malignant tumors. 
In particular, the Weiss system is widely used, which as-
sesses a total of nine histologic features; Fuhrman nuclear 
grade, mitotic rate ＞5 per 50 high power field, atypical mi-
toses, clear cell composition less than 25% of the entire tu-
mor mass, diffuse architecture, necrosis, venous invasion, 
sinusoidal invasion, and capsular invasion. Cases meeting 
zero, two, or more of these criteria and the others are classi-
fied into benign, malignant, and borderline of uncertain 
malignant potential, respectively [2,3,7].
In addition, the immunohistochemical and molecular 
profile is used to investigate the nature of tumors [2]. This 
profile evaluates immunoreactivity to anti-mitochondrial 
antibody mES-13, vimentin, inhibin, and melan A. 
However, its usefulness for diagnosis is limited because of 
low immunohistochemical sensitivity. Therefore, histo-
logical assessment remains important in the diagnosis of 
adrenocortical neoplasms.
Our case was interesting because malignancy was clin-
ically suspected before the operation, but the mass was 
found to be an oncocytic adrenocortical tumor with un-
certain malignant potential through postoperative histo-
logic assessment. The immunohistochemical findings 
from preoperative biopsy were as follows: positive for cyto-
keratin, synaptophysin, inhibin, and melan A. Moreover, 
because an 18.2x12.3x16.9 cm large, mixed solid and cystic 
mass associated with necrosis was observed on the abdo-
men-pelvis CT image, malignancy was clinically 
suspected.
Oncocytic adrenocortical tumors with uncertain malig-
nant potential are a rare neoplasm and their clinical sig-
nificance and management are uncertain. Therefore, re-
view of similar borderline tumors is necessary. One such 
tumor is the prostatic stromal tumor of uncertain malig-
nant potential, or STUMP. Fukuhara et al reported that 
most STUMPs do not show aggressive behavior but did re-
cur or progress to stromal sarcoma after resection in a few 
cases [8].
Therefore, an oncocytic adrenocortical tumor with un-
certain malignant potential as in this case is considered to 
require long-term follow-up through clinical, hormonal, 
and imaging evaluation owing to its malignant potential. 
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